Pfizer Inc (PFE) 30.24 $PFE
Why Kandi Technologies Shot Higher and Apollo Group Fell After Hours
Jeremy Bowman, The Motley Fool - Motley Fool - Mon Jul 14, 9:00PM CDT
Stocks kicked off the week with a bang thanks to a strong report from Citigroup and more M&A deals in the health-care sector. The Dow Jones Industrial Average finished back above 17,000, gaining 112 points, or 0.7%, to finish at 17,055,...
AbbVie's Deal for Shire Benefits Investors in More Ways Than One
at The Street - Mon Jul 14, 3:40PM CDT
Upon completion of this deal, AbbVie's stock should head toward the $70 level in the next 12 to 18 months, representing gains of close to 30%.
Midday Glance: Pharmaceuticals companies
AP - Mon Jul 14, 12:30PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Early Glance: Pharmaceuticals companies
AP - Mon Jul 14, 9:47AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Pfizer (PFE) Approaches New Upside Target of $30.32
Comtex SmarTrend(R) - Mon Jul 14, 9:03AM CDT
Shares of Pfizer (NYSE
FE) have bullishly opened above the pivot of $30.00 today and have reached the first resistance level of $30.19. Should the shares continue to rise, the resistance pivots of $30.32 and $30.64 will be of interest.
Shire Opens Door to Takeover by AbbVie
at The Street - Mon Jul 14, 8:08AM CDT
Irish drugs maker Shire said it had entered detailed discussions with suitor AbbVie about a fifth takeover proposal after eliciting a sweetened bid that values its stock at $54 billion.
Johnson & Johnson Earnings: Can Pharma Keep Stoking Growth?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Jul 14, 6:00AM CDT
On Tuesday, Johnson & Johnson will release its quarterly report, and shareholders have been pleased with the stock's ascent to all-time record levels recently. Despite Johnson & Johnson having a wide array of health-care-related businesses...
Johnson & Johnson Prescribes Healthy Returns Without M&A or Breakup
at The Street - Sun Jul 13, 7:32PM CDT
'Bigger' only for the sake of getting bigger makes no sense. Not trusting management of the company to execute the business is the worst blunder of them all.
Tax Inversions: Why Are They So Popular?
Dan Caplinger, The Motley Fool - Motley Fool - Sun Jul 13, 7:05AM CDT
Recently, Medtronic and Covidien became the latest pair of companies to consider a high-value merger. One of the big motivations for these international mergers is the opportunity to do a tax inversion. But what exactly is a tax inversion, and...
Abbott, Nestle, Prepare to Profit from China���s Upcoming Baby Boom
at The Street - Fri Jul 11, 1:44PM CDT
The one-child policy has been relaxed, giving makers of baby formula and incubators more opportunities to make money
Most active New York Stock Exchange-traded stocks
AP - Thu Jul 10, 12:44PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
'Mad Money' Lightning Round: AT&T Is a Buy
at The Street - Thu Jul 10, 5:00AM CDT
Cramer wants to own WhiteWave Foods, likes Johnson & Johnson over Pfizer and wants you to stay away from Gogo.
Jim Cramer's 'Mad Money' Recap: Hunting for Bargains
at The Street - Wed Jul 09, 6:53PM CDT
All you need to do is look at the last quarter's winners, Cramer advises.
AbbVie Boosts Offer for UK-Based Shire Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 09, 3:30PM CDT
AbbVie Inc. (ABBV) continues to pursue Shire (SHPG) and has now come up with a fourth proposal.
Who pays your doc? Coming soon to a site near you
By MATTHEW PERRONE - AP - Wed Jul 09, 1:18PM CDT
WASHINGTON (AP) — When many of us have a medical appointment we're concerned about our finances: how much will we owe out-of-pocket? What's our co-pay? But next time, you may also want to ask your doctors about their financial situation.
Dow Today: American Express (AXP) Leads The Day Higher, Pfizer (PFE) Lags
at The Street - Wed Jul 09, 9:00AM CDT
The Dow component leading the way higher looks to be American Express (NYSE: AXP ), which is sporting a 92-cent gain (+1%) bringing the stock to $95.23. Holding back the Dow today is Pfizer (NYSE: PFE ), which is lagging the broader Dow index...
Why Kandi Technologies Shot Higher and Apollo Group Fell After Hours
Jeremy Bowman, The Motley Fool - Motley Fool - Mon Jul 14, 9:00PM CDT
Stocks kicked off the week with a bang thanks to a strong report from Citigroup and more M&A deals in the health-care sector. The Dow Jones Industrial Average finished back above 17,000, gaining 112 points, or 0.7%, to finish at 17,055,...
AbbVie's Deal for Shire Benefits Investors in More Ways Than One
at The Street - Mon Jul 14, 3:40PM CDT
Upon completion of this deal, AbbVie's stock should head toward the $70 level in the next 12 to 18 months, representing gains of close to 30%.
Midday Glance: Pharmaceuticals companies
AP - Mon Jul 14, 12:30PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Early Glance: Pharmaceuticals companies
AP - Mon Jul 14, 9:47AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Pfizer (PFE) Approaches New Upside Target of $30.32
Comtex SmarTrend(R) - Mon Jul 14, 9:03AM CDT
Shares of Pfizer (NYSE
FE) have bullishly opened above the pivot of $30.00 today and have reached the first resistance level of $30.19. Should the shares continue to rise, the resistance pivots of $30.32 and $30.64 will be of interest. Shire Opens Door to Takeover by AbbVie
at The Street - Mon Jul 14, 8:08AM CDT
Irish drugs maker Shire said it had entered detailed discussions with suitor AbbVie about a fifth takeover proposal after eliciting a sweetened bid that values its stock at $54 billion.
Johnson & Johnson Earnings: Can Pharma Keep Stoking Growth?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Jul 14, 6:00AM CDT
On Tuesday, Johnson & Johnson will release its quarterly report, and shareholders have been pleased with the stock's ascent to all-time record levels recently. Despite Johnson & Johnson having a wide array of health-care-related businesses...
Johnson & Johnson Prescribes Healthy Returns Without M&A or Breakup
at The Street - Sun Jul 13, 7:32PM CDT
'Bigger' only for the sake of getting bigger makes no sense. Not trusting management of the company to execute the business is the worst blunder of them all.
Tax Inversions: Why Are They So Popular?
Dan Caplinger, The Motley Fool - Motley Fool - Sun Jul 13, 7:05AM CDT
Recently, Medtronic and Covidien became the latest pair of companies to consider a high-value merger. One of the big motivations for these international mergers is the opportunity to do a tax inversion. But what exactly is a tax inversion, and...
Abbott, Nestle, Prepare to Profit from China���s Upcoming Baby Boom
at The Street - Fri Jul 11, 1:44PM CDT
The one-child policy has been relaxed, giving makers of baby formula and incubators more opportunities to make money
Most active New York Stock Exchange-traded stocks
AP - Thu Jul 10, 12:44PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
'Mad Money' Lightning Round: AT&T Is a Buy
at The Street - Thu Jul 10, 5:00AM CDT
Cramer wants to own WhiteWave Foods, likes Johnson & Johnson over Pfizer and wants you to stay away from Gogo.
Jim Cramer's 'Mad Money' Recap: Hunting for Bargains
at The Street - Wed Jul 09, 6:53PM CDT
All you need to do is look at the last quarter's winners, Cramer advises.
AbbVie Boosts Offer for UK-Based Shire Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 09, 3:30PM CDT
AbbVie Inc. (ABBV) continues to pursue Shire (SHPG) and has now come up with a fourth proposal.
Who pays your doc? Coming soon to a site near you
By MATTHEW PERRONE - AP - Wed Jul 09, 1:18PM CDT
WASHINGTON (AP) — When many of us have a medical appointment we're concerned about our finances: how much will we owe out-of-pocket? What's our co-pay? But next time, you may also want to ask your doctors about their financial situation.
Dow Today: American Express (AXP) Leads The Day Higher, Pfizer (PFE) Lags
at The Street - Wed Jul 09, 9:00AM CDT
The Dow component leading the way higher looks to be American Express (NYSE: AXP ), which is sporting a 92-cent gain (+1%) bringing the stock to $95.23. Holding back the Dow today is Pfizer (NYSE: PFE ), which is lagging the broader Dow index...
